AT
Aditya Tolia
Private Equity Senior Analyst
OrbiMed
Private Equity Senior Analyst at OrbiMed with prior Investec and PwC banking experience.
Bio
Professional summary
Clay DeMarcus is a Principal at OrbiMed focused on medical technology and other non-therapeutics areas of venture-stage investing. He joined OrbiMed in 2021 after working at BofA Securities as a Vice President on the medical technology equity research team and earlier as an Investment Banking Associate in healthcare. He previously worked in management consulting at Accenture Strategy.
Background
Career, education, and skills
Career history
- OrbiMedPrincipal2021 – Present
- BofA SecuritiesVice President, Medical Technology Equity Research
- BofA SecuritiesInvestment Banking Associate, Healthcare
- Accenture StrategyManagement Consultant, Operations Practice
Education
- Emory University Goizueta Business SchoolM.B.A.
- Vanderbilt UniversityB.Sc.
Other partners at OrbiMed
12 more profiles
Alexis Megibow
Private Equity Associate
OrbiMed
Private Equity Associate at OrbiMed.
Ankesh Bhansali
Managing Director
OrbiMed
OrbiMed Asia Managing Director focused on healthcare private equity.
Arun Sadhanandham
Managing Director
OrbiMed
OrbiMed Asia Managing Director investing in healthcare private equity.
BC
Brendan Weber, CFA
Principal
OrbiMed
Principal on OrbiMed's Credit & Royalty team focused on structured credit and royalty financings.
CG
Carl Gordon
Managing Partner
OrbiMed
OrbiMed Managing Partner leading private equity and biotech company formation.
Carl L. Gordon
Managing Partner
OrbiMed
Carl L. Gordon is a Managing Partner at OrbiMed and leads the firm's private equity team.
CN
Carter Neild
Managing Partner
OrbiMed
OrbiMed Managing Partner focused on healthcare royalties and Asia private investments.
CS
Cooper Steputis
Private Equity / Venture Capital
OrbiMed
Healthcare private equity and venture investor with prior investment banking experience.
Daniel Ying
Executive Director
OrbiMed
OrbiMed Asia Executive Director focused on pharma and biotech investments.
David Bonita
General Partner
OrbiMed
OrbiMed General Partner and physician-investor in healthcare and therapeutics.
David Wang
Partner
OrbiMed
OrbiMed Asia Partner focused on Greater China healthcare investments.